J&J Abandons Bankruptcy Gambit; 67,000+ Talc Cancer Claims Head Back to Court
J&J has dropped its bankruptcy strategy after three failures and won't appeal its latest dismissal — sending 67,000+ talc cancer claims back to traditional courts.
By 411 Press Newsroom2 min read
Johnson & Johnson has abandoned its bankruptcy strategy for resolving talcum-powder cancer claims after three unsuccessful attempts, confirming in late April that it will not appeal its latest bankruptcy dismissal. The decision returns all pending talc lawsuits to traditional court proceedings. As of May 2026, at least 67,376 claims have been consolidated in the multidistrict litigation against the company.
For plaintiffs who allege J&J's talc products caused ovarian cancer and mesothelioma, the move ends a years-long detour and puts their cases back in front of juries.
What the "bankruptcy gambit" was
J&J never filed for bankruptcy itself. Instead it used a maneuver critics call the "Texas two-step": it spun off its talc liabilities into a separate subsidiary and put only that subsidiary into bankruptcy — an attempt to halt tens of thousands of lawsuits and force them into a single bankruptcy settlement on the company's terms, while the profitable parent stayed out of court.
Courts rejected the approach three times, generally on the ground that a financially healthy company cannot use a subsidiary's bankruptcy to escape mass-tort liability. With the third dismissal now final and unappealed, that strategy is over.
Why this matters beyond J&J
The talc fight has become the test case for whether large, solvent corporations can use bankruptcy law to cap mass-tort exposure. The repeated rejections — and J&J's decision to stop trying — are a significant marker for every other company watching whether the "two-step" is a viable escape hatch. For now, the answer from the courts has been no.
What happens next
With the claims back in the regular court system:
- Individual and consolidated cases proceed toward trial in the MDL and state courts
- Expert testimony on whether talc caused the plaintiffs' cancers will again be litigated case by case
- Settlement pressure shifts, because J&J can no longer hold the threat of a bankruptcy cram-down over claimants
411 Press covers mass-tort litigation as accountability news — a record of what the courts conclude and what it means for the people the outcomes affect. We'll track the talc cases as they return to trial.
Related coverage
